Weina Guo
Nanjing University of Chinese Medicine(CN)Nanjing Traditional Chinese Medicine Hospital(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Gut microbiota and health, Inflammatory Bowel Disease, Rheumatoid Arthritis Research and Therapies, Hepatitis B Virus Studies
Most-Cited Works
- → Diabetes is a risk factor for the progression and prognosis of COVID‐19(2020)1,443 cited
- → Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway(2022)175 cited
- → Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease(2020)174 cited
- → Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19(2020)85 cited
- → A novel simple scoring model for predicting severity of patients with SARS‐CoV‐2 infection(2020)70 cited
- → Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice(2019)58 cited
- → Depletion of Gut Microbiota Impairs Gut Barrier Function and Antiviral Immune Defense in the Liver(2021)49 cited
- → Beneficial Effects of Celastrol on Immune Balance by Modulating Gut Microbiota in Experimental Ulcerative Colitis Mice(2022)49 cited
- → HBV研究常用的动物模型(2018)43 cited
- → Two Spx Regulators Modulate Stress Tolerance and Virulence in Streptococcus suis Serotype 2(2014)39 cited